share_log

Altria | 10-Q: Q2 2024 Earnings Report

Altria | 10-Q: Q2 2024 Earnings Report

奧馳亞 | 10-Q：2024財年二季報
美股SEC公告 ·  2024/07/31 19:26

Moomoo AI 已提取核心訊息

Altria Group reported Q2 2024 net revenues decreased 4.6% to $6.2 billion, while net earnings surged 79.6% to $3.8 billion, primarily driven by the $2.7 billion gain from the IQOS System commercialization rights sale. Adjusted earnings declined 3.8% to $2.3 billion due to lower operating income. The company recorded a $354 million non-cash impairment charge for the Skoal trademark.Smokeable products segment revenues fell 5.6% to $5.5 billion on lower shipment volumes, while oral tobacco products revenue grew 4.6% to $711 million despite volume declines. Marlboro maintained a 42.0% retail share, while on! nicotine pouches achieved 8.1% share of the oral tobacco category. The company expanded NJOY distribution to over 100,000 stores with 5.5% e-vapor category share.Altria reaffirmed its smoke-free transition vision, targeting 35% smoke-free volume growth and $5 billion in smoke-free revenues by 2028. The company maintained its progressive dividend policy targeting mid-single digit annual growth and completed a $2.4 billion accelerated share repurchase program using proceeds from the partial sale of its ABI stake.
Altria Group reported Q2 2024 net revenues decreased 4.6% to $6.2 billion, while net earnings surged 79.6% to $3.8 billion, primarily driven by the $2.7 billion gain from the IQOS System commercialization rights sale. Adjusted earnings declined 3.8% to $2.3 billion due to lower operating income. The company recorded a $354 million non-cash impairment charge for the Skoal trademark.Smokeable products segment revenues fell 5.6% to $5.5 billion on lower shipment volumes, while oral tobacco products revenue grew 4.6% to $711 million despite volume declines. Marlboro maintained a 42.0% retail share, while on! nicotine pouches achieved 8.1% share of the oral tobacco category. The company expanded NJOY distribution to over 100,000 stores with 5.5% e-vapor category share.Altria reaffirmed its smoke-free transition vision, targeting 35% smoke-free volume growth and $5 billion in smoke-free revenues by 2028. The company maintained its progressive dividend policy targeting mid-single digit annual growth and completed a $2.4 billion accelerated share repurchase program using proceeds from the partial sale of its ABI stake.
奧馳亞集團報告稱2024年第二季度淨營業收入下降4.6%，達到62億，而凈利潤暴漲79.6%，達到38億，這主要得益於27億的IQOS系統商業化權利銷售收益。調整後的收益因運營收入下降而減少3.8%至23億。公司記錄了35400萬的非現金減值費用，涉及Skoal商標。可吸菸產品部門的營業收入因出貨量下降而下降5.6%，至55億，而口腔煙草製品的營業收入儘管成交量下降，仍增長4.6%至71100萬。萬寶路維持42.0%的零售份額，on!尼古丁袋在口腔菸草類別中達到了8.1%的市場份額。公司將NJOY的分銷擴展到超過100,000家商店，並在電子蒸汽類別中佔據5.5%的市場份額。奧馳亞重申其無煙轉型願景，目標是到2028年實現35%的無煙成交量增長和50億的無煙營收。公司保持其漸進的股息政策，目標是每年中個位數的增長，並利用部分出售ABI股份的收益完成了一項24億的加速回購計劃。
奧馳亞集團報告稱2024年第二季度淨營業收入下降4.6%，達到62億，而凈利潤暴漲79.6%，達到38億，這主要得益於27億的IQOS系統商業化權利銷售收益。調整後的收益因運營收入下降而減少3.8%至23億。公司記錄了35400萬的非現金減值費用，涉及Skoal商標。可吸菸產品部門的營業收入因出貨量下降而下降5.6%，至55億，而口腔煙草製品的營業收入儘管成交量下降，仍增長4.6%至71100萬。萬寶路維持42.0%的零售份額，on!尼古丁袋在口腔菸草類別中達到了8.1%的市場份額。公司將NJOY的分銷擴展到超過100,000家商店，並在電子蒸汽類別中佔據5.5%的市場份額。奧馳亞重申其無煙轉型願景，目標是到2028年實現35%的無煙成交量增長和50億的無煙營收。公司保持其漸進的股息政策，目標是每年中個位數的增長，並利用部分出售ABI股份的收益完成了一項24億的加速回購計劃。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

獨立文件5  查看翻譯

獨立文件6  查看翻譯

獨立文件7  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    相關股票 相關股票
    代碼 迷你走勢 最新價
    22nd Century
    XXII
    -- 3.1900
    菲利普莫里斯
    PM
    -- 150.460
    霧麻科技
    ISPR
    -- 4.360
    奧馳亞
    MO
    -- 53.290
    霧芯科技
    RLX
    -- 2.340
    解鎖完整榜單
    重估中國資產
    繼中國開創性的DeepSeek技術推出之後，華爾街大行重估對中國市場的投資前景。
    熱門討論
    特斯拉績後巨震，後市你怎麽看？
    特斯拉2024年Q4營收257.1億美元，同比增長2%，不及預期。Cybercab計劃2026年投產，預計車輛業務將於2025年恢復增長。面對特朗普回歸，特斯拉股價能否在2025年繼續攀升？
    TSLA收益預覽：猜測開盤價贏取獎勵！